They're Not Selling Apples Just Yet

Staff Writer

“The greatest risk in periods of tight economic times and tight budgets is to stop taking risks.” That FDR-style aphorism about the need to spend more money on risky science even in hard times—uttered by former U.S. National Institutes of Health Director Elias Zerhouni—appears in a paper issued Friday by the National Academies, a summary of last month’s so-called Biosummit of biomedical research leaders. The report, which says recommendations will follow, signals the start of an effort to get comment from the field and to draw up a long-term agenda for bioscience later this year.